Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

DEHOP phase II data discussed at Digestive Disease Week

May 20, 1998

S-Nitrosocaptopril combines NO-donor and ACE-inhibitor effects in a single molecule

May 20, 1998

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

DISC HSV reported to be safe and immunogenic in phase I trials

May 20, 1998

Helicase-primase, an enzyme target for the design of new antiviral agents

May 19, 1998

IRL-3630: a bifunctional ET antagonist for respiratory ailments

May 12, 1998

Comparative studies of L-0066 in animal models of allergic bronchial inflammation

May 11, 1998

Levalbuterol shows improved therapeutic ratio over racemic albuterol

May 8, 1998

P&U reports antiasthma agent with a novel mechanism of action

May 8, 1998

Profile of BIIC-1996, a novel dual NK1/NK2 antagonist for respiratory indications

May 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...